|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 219-229, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
NE Doherty 3d, JF Turocy, GA Geffin, DD O'Keefe, JS Titus and WM Daggett
We tested the effects of glucose and oxygen in cardioplegic solutions on
myocardial protection in the isolated perfused working rat heart. Recovery
from 2 hours' hypothermic (8 degrees C) cardioplegic arrest was examined in
93 hearts. Cardioplegic solution, which was delivered every 15 minutes, was
supplemented with glucose 28 mmol/L as a substrate or sucrose 28 mmol/L as
a nonmetabolizable osmotic control; it was equilibrated with either 98%
oxygen or 98% nitrogen, both with 2% carbon dioxide. Four combinations of
hyperkalemic cardioplegic solution were studied: nitrogen-sucrose,
nitrogen-glucose, oxygen- sucrose, and oxygen-glucose. During hypothermic
arrest, oxygenation of cardioplegic solution greatly reduced myocardial
lactate production and prevented ischemic contracture as indicated by
coronary vascular resistance. Glucose increased lactate production modestly
but significantly only when the cardioplegic solution was nitrogenated.
Although end-arrest myocardial adenosine triphosphate and creatine
phosphate were greatly increased by oxygenation of cardioplegic solution (p
less than 0.005), we could not detect improved preservation of these
high-energy phosphates by glucose. Averaged over reperfusion, percent
recovery of cardiac output for the nitrogen-sucrose, nitrogen- glucose,
oxygen-sucrose, and oxygen-glucose solutions was 32.3% +/- 6.1%, 45.9% +/-
4.6%, 44.5% +/- 4.6%, and 62.2% +/- 4.5%, respectively. Oxygenation of the
glucose solution or addition of glucose to the oxygenated solution
significantly improved recovery of cardiac output. The benefits of glucose
and oxygen were additive, so that the oxygen- glucose cardioplegic solution
provided the best functional recovery. We conclude that the addition of
glucose to the fully oxygenated multidose cold cardioplegic solution
improves functional recovery without increasing lactate production during
arrest.
ARTICLES
Benefits of glucose and oxygen in multidose cold cardioplegia
Department of Surgery, Massachusetts General Hospital, Boston 02114.
This article has been cited by other articles:
![]() |
B. Tunerir, R. Aslan, S. Isiksoy, O. Colak, Y. Besogul, and T. Kural Benefits of Glucose-Insulin-Potassium Before Mitral Valve Replacement Asian Cardiovasc Thorac Ann, December 1, 1998; 6(4): 273 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rao, F. Merante, R. D. Weisel, T. Shirai, J. S. Ikonomidis, G. Cohen, L. C. Tumiati, N. Shiono, R.-K. Li, D. A. Mickle, et al. Insulin stimulates pyruvate dehydrogenase and protects humanventricular cardiomyocytes from simulated ischemia J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 485 - 489. [Abstract] [Full Text] |
||||
![]() |
D. D. Belke, L. C. H. Wang, and G. D. Lopaschuk Effects of hypothermia on energy metabolism in rat and Richardson's ground squirrel hearts J Appl Physiol, April 1, 1997; 82(4): 1210 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Ning, Keith.F. Childs, and S. F. Bolling Glucose Level and Myocardial Recovery After Warm Arrest Ann. Thorac. Surg., December 1, 1996; 62(6): 1825 - 1829. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |